NATIONAL

FDA Panel Debates Lower-Dose Moderna COVID Shots For Booster

0
FILE - This Wednesday, Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. U.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose. Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand. On Thursday, Oct. 14, 2021, advisers to the Food and Drug Administration evaluated the evidence that Moderna boosters should be offered, too -- and on Friday, they’ll tackle the same question for those who got Johnson & Johnson’s vaccine. (AP Photo/David Zalubowski, File)

(AP) – U.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot — this time, using half the original dose. Already certain high-risk groups who got their initial Pfizer vaccinations at least six months ago are rolling up their sleeves. Thursday and Friday, advisers to the Food and Drug Administration will recommend if and when to offer boosters to both Moderna and Johnson & Johnson vaccine recipients. Final decisions are expected next week. U.S. officials stress that the priority is to get shots to the 66 million unvaccinated Americans who are eligible.

South Texas Officials Happy That Nonessential Travel From Mexico Will Resume

Previous article

United Airlines Will Add New International Routes Next Year

Next article

You may also like

More in NATIONAL